Prolonged Selection of Pfmdr1 Polymorphisms After Treatment of Falciparum Malaria with Artemether-lumefantrine in Uganda

Overview

Journal J Infect Dis

Publisher Oxford University Press

Specialty Infectious Diseases

Date 2011 Sep 2

PMID 21881128

Citations 53

Authors

Frederick N Baliraine

Philip J Rosenthal

Affiliations

Soon will be listed here.

Abstract

We compared the prevalence of key pfmdr1 alleles between pretreatment Plasmodium falciparum parasite isolates and parasites that emerged after treatment of uncomplicated malaria in a longitudinal cohort of Ugandan children. The pfmdr1 86N, 184F, and 1246D alleles were selected after treatment with artemether-lumefantrine, but not after artesunate-amodiaquine or amodiaquine-sulfadoxine-pyrimethamine. Remarkably, selection persisted in infections presenting up to about 60 days after treatment with artemether-lumefantrine. Thus, parasites selected for decreased drug sensitivity can appear long after predicted exposure to antimalarial drugs. Continued surveillance of the clinical efficacy and in vitro activity of new combination therapies is warranted.

Citing Articles

Rebound of multiple infections and prevalence of anti-malarial resistance associated markers following malaria upsurges in Dielmo village, Senegal, West Africa.

Wotodjo A, Oboh M, Doucoure S, Diagne N, Diene-Sarr F, Niang M Malar J. 2023; 22(1):257.

PMID: 37670357 PMC: 10478411. DOI: 10.1186/s12936-023-04694-0.

Drug resistance of Plasmodium falciparum and Plasmodium vivax isolates in Indonesia.

Rahmasari F, Asih P, Dewayanti F, Rotejanaprasert C, Charunwatthana P, Imwong M Malar J. 2022; 21(1):354.

PMID: 36443817 PMC: 9703442. DOI: 10.1186/s12936-022-04385-2.

susceptibility profile of clinical isolates from Ghana to antimalarial drugs and polymorphisms in resistance markers.

Zhao W, Li X, Yang Q, Zhou L, Duan M, Pan M Front Cell Infect Microbiol. 2022; 12:1015957.

PMID: 36310880 PMC: 9614232. DOI: 10.3389/fcimb.2022.1015957.

Temporal trends in molecular markers of drug resistance in Plasmodium falciparum in human blood and profiles of corresponding resistant markers in mosquito oocysts in Asembo, western Kenya.

Zhou Z, Gimnig J, Sergent S, Liu Y, Abongo B, Otieno K Malar J. 2022; 21(1):265.

PMID: 36100912 PMC: 9472345. DOI: 10.1186/s12936-022-04284-6.

Plasmodium falciparum merozoite invasion ligands, linked antimalarial resistance loci and ex vivo responses to antimalarials in The Gambia.

Mbye H, Mane K, Diop M, Demba M, Bojang F, Mohammed N J Antimicrob Chemother. 2022; 77(11):2946-2955.

PMID: 35904009 PMC: 9616547. DOI: 10.1093/jac/dkac244.

References

Clark T, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, Greenhouse B, Staedke S . Incidence of malaria and efficacy of combination antimalarial therapies over 4 years in an urban cohort of Ugandan children. PLoS One. 2010; 5(7):e11759. PMC: 2912768. DOI: 10.1371/journal.pone.0011759. View

Valderramos S, Fidock D . Transporters involved in resistance to antimalarial drugs. Trends Pharmacol Sci. 2006; 27(11):594-601. PMC: 2944664. DOI: 10.1016/j.tips.2006.09.005. View

Duraisingh M, Jones P, Sambou I, von Seidlein L, Pinder M, Warhurst D . The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Mol Biochem Parasitol. 2000; 108(1):13-23. DOI: 10.1016/s0166-6851(00)00201-2. View

Stepniewska K, White N . Pharmacokinetic determinants of the window of selection for antimalarial drug resistance. Antimicrob Agents Chemother. 2008; 52(5):1589-96. PMC: 2346628. DOI: 10.1128/AAC.00903-07. View

Happi C, Gbotosho G, Folarin O, Sowunmi A, Hudson T, ONeil M . Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria. Antimicrob Agents Chemother. 2008; 53(3):888-95. PMC: 2650543. DOI: 10.1128/AAC.00968-08. View

Dorsey G, Kamya M, Singh A, Rosenthal P . Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda. J Infect Dis. 2001; 183(9):1417-20. DOI: 10.1086/319865. View

Nsobya S, Kiggundu M, Nanyunja S, Joloba M, Greenhouse B, Rosenthal P . In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda. Antimicrob Agents Chemother. 2010; 54(3):1200-6. PMC: 2825959. DOI: 10.1128/AAC.01412-09. View

Reed M, Saliba K, Caruana S, Kirk K, Cowman A . Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature. 2000; 403(6772):906-9. DOI: 10.1038/35002615. View

Humphreys G, Merinopoulos I, Ahmed J, Whitty C, Mutabingwa T, Sutherland C . Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria. Antimicrob Agents Chemother. 2006; 51(3):991-7. PMC: 1803116. DOI: 10.1128/AAC.00875-06. View

10.

Dokomajilar C, Nsobya S, Greenhouse B, Rosenthal P, Dorsey G . Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic. Antimicrob Agents Chemother. 2006; 50(5):1893-5. PMC: 1472234. DOI: 10.1128/AAC.50.5.1893-1895.2006. View

11.

Duraisingh M, Roper C, Walliker D, Warhurst D . Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum. Mol Microbiol. 2000; 36(4):955-61. DOI: 10.1046/j.1365-2958.2000.01914.x. View

12.

Mwai L, Kiara S, Abdirahman A, Pole L, Rippert A, Diriye A . In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1. Antimicrob Agents Chemother. 2009; 53(12):5069-73. PMC: 2786317. DOI: 10.1128/AAC.00638-09. View

13.

Huijben S, Nelson W, Wargo A, Sim D, Drew D, Read A . Chemotherapy, within-host ecology and the fitness of drug-resistant malaria parasites. Evolution. 2010; 64(10):2952-68. PMC: 3066636. DOI: 10.1111/j.1558-5646.2010.01068.x. View

14.

Mwesigwa J, Parikh S, McGee B, German P, Drysdale T, Kalyango J . Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda. Antimicrob Agents Chemother. 2009; 54(1):52-9. PMC: 2798532. DOI: 10.1128/AAC.00679-09. View

15.

Dorsey G, Staedke S, Clark T, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C . Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial. JAMA. 2007; 297(20):2210-9. DOI: 10.1001/jama.297.20.2210. View